What does YK Bioventures invest in?
YK Bioventures invests most often at Series B (100% of the rounds on record), in sectors such as Venture Capital & Private Equity.

Last cheque observed Oct 2026; 2 cheques on record.
Deploying nowNew fund, Jul 2026VC firm
2 cheques in the last 12 months
Mostly Series B: 100% of its rounds
Every round we can evidence, newest first2 appearances
1 round
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Named by the firm itself, on a filing, its Form ADV or its company registration2 named
We also hold 2 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
From the firm's own filings with the SEC, which it must file accurately by law
YK Bioventures invests most often at Series B (100% of the rounds on record), in sectors such as Venture Capital & Private Equity.
2 investments on record, 2 of them in the last 12 months. The most recent was in Oct 2026.
Its most recent investments on record: Bolt Biotherapeutics (Undisclosed round, Oct 2026) and Protego Biopharma (Series B, Dec 2025).
The median round it joins is $125M.
Yes: it is actively investing, with 2 investments in the last 12 months.
YK Bioventures is a VC firm.
About $55M, as gross assets of its private funds (Oct 2026).
Its latest fund filing with the SEC was in Jul 2026.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it